Expression of CD19B Cells and Involvement of Serum Breg in Pathogenesis of Immune Thrombocytopenia.
10.19746/j.cnki.issn.1009-2137.2019.03.044
- Author:
Zheng-Xia DI
1
;
Yan GENG
2
;
Xiao-Lin SUN
3
;
Ai-Yun SU
3
;
Kun GUO
3
;
Qing LI
4
Author Information
1. Department of Clinical Laboratoial Examination,Zibo Municipal First Hospital, Zibo 255200, Shandong Province, China.
2. Department of Hematology, Zibo Municipal First Hospital, Zibo 255200, Shandong Province, China.
3. Department of Clinical Laboratoial Examination, Zibo Municipal First Hospital, Zibo 255200, Shandong Province, China.
4. Department of Clinical Laboratoial Examination, Zibo Municipal First Hospital, Zibo 255200, Shandong Province, China,E-mail: liqingfugd@163.com.
- Publication Type:Journal Article
- MeSH:
Antigens, CD19;
B-Lymphocytes, Regulatory;
Cell Count;
Humans;
Purpura, Thrombocytopenic, Idiopathic
- From:
Journal of Experimental Hematology
2019;27(3):911-915
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the expression of CD19B cells in immune thrombocytopenia patients, and to analyze the involvement of serum Breg in the pathogenesis of ITP.
METHODS:A total of 68 ITP patients admitted in department of hematology in our hospital from August 2015 to August 2018 were selected and enrolled in ITP group. 30 healthy individuals who were admitted to physical examination center at the same time were selected and enrolled in control group. The expression of peripheral blood lymphocyte subsets CD19 and peripheral blood Breg cells were measured by flow cytometry. The difference between the ITP group and the control group was compared. The IL-10 mRNA and TGF-β1 mRNA levels were detected by RT-PCR. Correlations between the ratio of peripheral blood Breg cells and the expression of IL-10 mRNA and TGF-β1 mRNA in patients with immune thrombocytopenia, were analyzed.
RESULTS:Expression of CD19 in ITP group was significantly higher than that in control group. The difference between the two groups was statistically significant. Expression level of serum Breg cells in ITP group was lower than that in control group. IL-10 mRNA level in ITP group was significantly lower than that in control group. IL-10 mRNA level after treatment was significantly higher than that before treatment. In addition, TGF-β1 mRNA level in newly diagnosed ITP group was significantly higher than that in control group. After treatment, the TGF-β1 mRNA level was higher than that before treatment. The ratio of peripheral blood Breg cells positively correlated with IL-10 mRNA expression (r=0.968, P＜0.05), however, there was no correlation between peripheral blood Breg cell ratio and TGF-β1 mRNA expression (r=0.502, P＞0.05).
CONCLUSION:Expression of CD19 cells in ITP patients is increased. Breg cells may participate in the genesis of immune thrombocytopenia. The abnormal expression of Breg cells relates with the pathogenesis of immune thrombocytopenia.
